ArticleMolecular therapy oncolytics2023

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors.

Tomoharu Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.